*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 7943.3 | nM | PMID[468870] |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | = | 7943.3 | nM | PMID[468871] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 2511.9 | nM | PMID[468871] |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 2511.9 | nM | PMID[468870] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 14125.4 | nM | PMID[468870] |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 91999.7 | nM | PMID[468872] |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 12589.3 | nM | PMID[468870] |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | Potency | = | 6309.6 | nM | PMID[468873] |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | Potency | = | 15848.9 | nM | PMID[468871] |
NPT211 | Individual Protein | Hypoxia-inducible factor 1 alpha | Homo sapiens | Potency | = | 7943.3 | nM | PMID[468871] |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 19952.6 | nM | PMID[468870] |
NPT54 | Individual Protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 5011.9 | nM | PMID[468870] |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | Potency | = | 2818.4 | nM | PMID[468871] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 12589.3 | nM | PMID[468871] |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 12559.4 | nM | PMID[468870] |
NPT150 | Individual Protein | Anthrax lethal factor | Bacillus anthracis | Potency | = | 15848.9 | nM | PMID[468873] |
NPT45 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[468871] |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 11220.2 | nM | PMID[468870] |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 22387.2 | nM | PMID[468870] |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 3162.3 | nM | PMID[468870] |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 25118.9 | nM | PMID[468871] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 125.9 | nM | PMID[468873] |
NPT501 | Individual Protein | Alpha-galactosidase A | Homo sapiens | Potency | = | 11220.2 | nM | PMID[468870] |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 19952.6 | nM | PMID[468871] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 1000.0 | nM | PMID[468871] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 100.0 | nM | PMID[468871] |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | Potency | = | 25118.9 | nM | PMID[468873] |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[468871] |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 1584.9 | nM | PMID[468873] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | = | 7079.5 | nM | PMID[468870] |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 12589.3 | nM | PMID[468871] |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 794.3 | nM | PMID[468870] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 3662.6 | nM | PMID[468872] |
NPT1139 | Individual Protein | Arachidonate 15-lipoxygenase, type II | Homo sapiens | Potency | n.a. | 1258.9 | nM | PMID[468870] |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[468872] |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | n.a. | 1835.5 | nM | PMID[468872] |
NPT1623 | Individual Protein | DNA polymerase III | Bacillus subtilis (strain 168) | Potency | n.a. | 11917.3 | nM | PMID[468872] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 794.3 | nM | PMID[468872] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 3981.1 | nM | PMID[468870] |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | n.a. | 4775.5 | nM | PMID[468872] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[468872] |
NPT1139 | Individual Protein | Arachidonate 15-lipoxygenase, type II | Homo sapiens | Potency | n.a. | 3162.3 | nM | PMID[468871] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 20587.8 | nM | PMID[468872] |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | n.a. | 15848.9 | nM | PMID[468872] |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | AC50 | = | 12589.25 | nM | PMID[468871] |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | AC50 | = | 15848.93 | nM | PMID[468871] |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | AC50 | = | 25118.86 | nM | PMID[468871] |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | AC50 | = | 39810.72 | nM | PMID[468871] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[468872] |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[468872] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 1683.4 | nM | PMID[468872] |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | n.a. | 14068.4 | nM | PMID[468872] |
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[468872] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 89125.1 | nM | PMID[468872] |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[468872] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 33498.3 | nM | PMID[468875] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 18837.5 | nM | PMID[468875] |
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | n.a. | 21331.3 | nM | PMID[468872] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[468870] |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 26832.5 | nM | PubChem BioAssay data set |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 33491.5 | nM | PubChem BioAssay data set |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Potency | = | 10000.0 | nM | PMID[468870] |
NPT2 | Others | Unspecified | Potency | = | 19952.6 | nM | PMID[468870] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Potency | = | 12589.3 | nM | PMID[468870] |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 12995.3 | nM | PMID[468872] |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 1258.9 | nM | PMID[468870] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 158.5 | nM | PMID[468870] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Potency | = | 5011.9 | nM | PMID[468870] |
NPT796 | Individual Protein | Peripheral myelin protein 22 | Homo sapiens | Potency | = | 84921.4 | nM | PMID[468870] |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 631.0 | nM | PMID[468871] |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 18492.7 | nM | PMID[468872] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Potency | = | 3981.1 | nM | PMID[468870] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 14125.4 | nM | PMID[468870] |
NPT95 | Individual Protein | Muscarinic acetylcholine receptor M1 | Rattus norvegicus | Potency | = | 28.2 | nM | PMID[468871] |
NPT96 | Individual Protein | Thrombopoietin | Homo sapiens | Potency | = | 5011.9 | nM | PMID[468871] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Potency | = | 14125.4 | nM | PMID[468870] |
NPT2 | Others | Unspecified | Potency | = | 35481.3 | nM | PMID[468870] | |
NPT800 | Individual Protein | M-phase phosphoprotein 8 | Homo sapiens | Potency | n.a. | 23778.1 | nM | PMID[468872] |
NPT800 | Individual Protein | M-phase phosphoprotein 8 | Homo sapiens | Potency | n.a. | 25118.9 | nM | PMID[468870] |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 9466.2 | nM | PMID[468872] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 13115.4 | nM | PMID[468870] |
NPT2 | Others | Unspecified | Potency | n.a. | 29092.9 | nM | PMID[468872] | |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | n.a. | 2238.7 | nM | PMID[468870] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 16511.3 | nM | PMID[468870] |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | n.a. | 30131.3 | nM | PMID[468872] |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | n.a. | 15848.9 | nM | PMID[468870] |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | n.a. | 751.9 | nM | PMID[468872] |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | n.a. | 1778.3 | nM | PMID[468870] |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 12589.3 | nM | PMID[468872] |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 26679.5 | nM | PMID[468870] |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | n.a. | 3162.3 | nM | PMID[468870] |
NPT98 | Individual Protein | HERG | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[468870] |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | n.a. | 15003.0 | nM | PMID[468872] |
NPT2 | Others | Unspecified | Potency | n.a. | 791.1 | nM | PMID[468872] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1578.5 | nM | PMID[468871] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1578.5 | nM | PMID[468873] | |
NPT2 | Others | Unspecified | Potency | n.a. | 14125.4 | nM | PMID[468870] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1578.5 | nM | PMID[468874] | |
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[468872] |
NPT2 | Others | Unspecified | Potency | n.a. | 14068.4 | nM | PMID[468872] | |
NPT2 | Others | Unspecified | Potency | n.a. | 35338.3 | nM | PMID[468875] | |
NPT2 | Others | Unspecified | Potency | n.a. | 18356.4 | nM | PMID[468872] | |
NPT2 | Others | Unspecified | Potency | n.a. | 8199.5 | nM | PMID[468872] | |
NPT2 | Others | Unspecified | Potency | n.a. | 7079.5 | nM | PMID[468872] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1578.5 | nM | PMID[468875] | |
NPT2 | Others | Unspecified | Potency | n.a. | 6309.6 | nM | PMID[468872] | |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 8.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 4.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 2.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 64.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 32.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 1024.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 128.0 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 0.06 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 0.03 | ug.mL-1 | PMID[468877] |
NPT24842 | SINGLE PROTEIN | Acriflavine resistance protein B | Escherichia coli (strain K12) | MIC | = | 16.0 | ug.mL-1 | PMID[468877] |
NPT2 | Others | Unspecified | Potency | n.a. | 14960.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 9439.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 13333.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 29849.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 8412.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 23710.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 30106.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 10590.9 | nM | PubChem BioAssay data set |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC254833 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC228343 |
0.9604 | High Similarity | NPC239291 |
0.9505 | High Similarity | NPC471511 |
0.9346 | High Similarity | NPC120280 |
0.9333 | High Similarity | NPC174096 |
0.9333 | High Similarity | NPC120982 |
0.9333 | High Similarity | NPC147634 |
0.9333 | High Similarity | NPC226401 |
0.9333 | High Similarity | NPC79793 |
0.932 | High Similarity | NPC477814 |
0.9245 | High Similarity | NPC179002 |
0.9245 | High Similarity | NPC187583 |
0.9245 | High Similarity | NPC257430 |
0.9238 | High Similarity | NPC55617 |
0.9238 | High Similarity | NPC62258 |
0.9216 | High Similarity | NPC196479 |
0.9208 | High Similarity | NPC223393 |
0.9126 | High Similarity | NPC120719 |
0.9065 | High Similarity | NPC297657 |
0.9018 | High Similarity | NPC117780 |
0.9018 | High Similarity | NPC242885 |
0.9018 | High Similarity | NPC227217 |
0.9018 | High Similarity | NPC95614 |
0.9018 | High Similarity | NPC232316 |
0.9018 | High Similarity | NPC165133 |
0.9018 | High Similarity | NPC56214 |
0.901 | High Similarity | NPC109955 |
0.8962 | High Similarity | NPC233835 |
0.8929 | High Similarity | NPC281298 |
0.8929 | High Similarity | NPC310338 |
0.8919 | High Similarity | NPC200988 |
0.8919 | High Similarity | NPC175799 |
0.8919 | High Similarity | NPC145023 |
0.8919 | High Similarity | NPC610 |
0.8911 | High Similarity | NPC132271 |
0.8911 | High Similarity | NPC82664 |
0.8911 | High Similarity | NPC292730 |
0.8911 | High Similarity | NPC473388 |
0.8911 | High Similarity | NPC216520 |
0.8899 | High Similarity | NPC471485 |
0.8889 | High Similarity | NPC268032 |
0.886 | High Similarity | NPC160380 |
0.886 | High Similarity | NPC38996 |
0.885 | High Similarity | NPC475245 |
0.8839 | High Similarity | NPC86198 |
0.8839 | High Similarity | NPC144343 |
0.8839 | High Similarity | NPC470626 |
0.8812 | High Similarity | NPC107522 |
0.8812 | High Similarity | NPC26244 |
0.8812 | High Similarity | NPC274678 |
0.8807 | High Similarity | NPC471179 |
0.8785 | High Similarity | NPC11554 |
0.8783 | High Similarity | NPC85488 |
0.8762 | High Similarity | NPC323810 |
0.8761 | High Similarity | NPC70084 |
0.8761 | High Similarity | NPC470215 |
0.8761 | High Similarity | NPC109371 |
0.8761 | High Similarity | NPC217174 |
0.8761 | High Similarity | NPC470214 |
0.875 | High Similarity | NPC293619 |
0.875 | High Similarity | NPC277588 |
0.875 | High Similarity | NPC16030 |
0.875 | High Similarity | NPC110764 |
0.8739 | High Similarity | NPC472893 |
0.8738 | High Similarity | NPC92730 |
0.8713 | High Similarity | NPC76938 |
0.8713 | High Similarity | NPC151715 |
0.8707 | High Similarity | NPC317769 |
0.8707 | High Similarity | NPC280704 |
0.8707 | High Similarity | NPC31344 |
0.8696 | High Similarity | NPC237667 |
0.8661 | High Similarity | NPC277394 |
0.8661 | High Similarity | NPC299252 |
0.8661 | High Similarity | NPC61062 |
0.8641 | High Similarity | NPC225464 |
0.8636 | High Similarity | NPC51698 |
0.8627 | High Similarity | NPC32714 |
0.8611 | High Similarity | NPC58427 |
0.8611 | High Similarity | NPC114392 |
0.8611 | High Similarity | NPC105727 |
0.8611 | High Similarity | NPC34864 |
0.8609 | High Similarity | NPC98305 |
0.8609 | High Similarity | NPC24125 |
0.8609 | High Similarity | NPC207613 |
0.8596 | High Similarity | NPC191866 |
0.8585 | High Similarity | NPC12278 |
0.8585 | High Similarity | NPC52087 |
0.8584 | High Similarity | NPC278652 |
0.8559 | High Similarity | NPC29008 |
0.8559 | High Similarity | NPC9067 |
0.8559 | High Similarity | NPC317869 |
0.8559 | High Similarity | NPC266705 |
0.8559 | High Similarity | NPC228771 |
0.8559 | High Similarity | NPC148627 |
0.8558 | High Similarity | NPC131587 |
0.8547 | High Similarity | NPC473451 |
0.8547 | High Similarity | NPC53567 |
0.8534 | High Similarity | NPC324571 |
0.8534 | High Similarity | NPC470212 |
0.8534 | High Similarity | NPC39029 |
0.8534 | High Similarity | NPC54872 |
0.8534 | High Similarity | NPC343720 |
0.8534 | High Similarity | NPC312675 |
0.8534 | High Similarity | NPC473853 |
0.8534 | High Similarity | NPC262156 |
0.8534 | High Similarity | NPC113865 |
0.8534 | High Similarity | NPC184651 |
0.8522 | High Similarity | NPC265454 |
0.8522 | High Similarity | NPC34634 |
0.8519 | High Similarity | NPC176527 |
0.8515 | High Similarity | NPC45040 |
0.8515 | High Similarity | NPC304541 |
0.8509 | High Similarity | NPC474040 |
0.8505 | High Similarity | NPC138942 |
0.8491 | Intermediate Similarity | NPC168829 |
0.8487 | Intermediate Similarity | NPC274356 |
0.8476 | Intermediate Similarity | NPC294741 |
0.8475 | Intermediate Similarity | NPC257682 |
0.8475 | Intermediate Similarity | NPC146355 |
0.8475 | Intermediate Similarity | NPC131747 |
0.8462 | Intermediate Similarity | NPC32674 |
0.8455 | Intermediate Similarity | NPC44732 |
0.8448 | Intermediate Similarity | NPC470848 |
0.8448 | Intermediate Similarity | NPC470849 |
0.8435 | Intermediate Similarity | NPC141791 |
0.8435 | Intermediate Similarity | NPC176893 |
0.8435 | Intermediate Similarity | NPC268572 |
0.8435 | Intermediate Similarity | NPC263386 |
0.8431 | Intermediate Similarity | NPC162314 |
0.8431 | Intermediate Similarity | NPC306884 |
0.8431 | Intermediate Similarity | NPC210497 |
0.8431 | Intermediate Similarity | NPC94139 |
0.8431 | Intermediate Similarity | NPC3358 |
0.8431 | Intermediate Similarity | NPC147284 |
0.8426 | Intermediate Similarity | NPC271274 |
0.8421 | Intermediate Similarity | NPC86947 |
0.8417 | Intermediate Similarity | NPC165045 |
0.8417 | Intermediate Similarity | NPC5428 |
0.8417 | Intermediate Similarity | NPC118533 |
0.8417 | Intermediate Similarity | NPC127587 |
0.8416 | Intermediate Similarity | NPC192 |
0.8411 | Intermediate Similarity | NPC79672 |
0.8411 | Intermediate Similarity | NPC288411 |
0.8396 | Intermediate Similarity | NPC91461 |
0.8396 | Intermediate Similarity | NPC12221 |
0.8396 | Intermediate Similarity | NPC7686 |
0.8396 | Intermediate Similarity | NPC40258 |
0.8393 | Intermediate Similarity | NPC165106 |
0.839 | Intermediate Similarity | NPC471693 |
0.839 | Intermediate Similarity | NPC136319 |
0.8381 | Intermediate Similarity | NPC132078 |
0.8381 | Intermediate Similarity | NPC216468 |
0.8381 | Intermediate Similarity | NPC51333 |
0.8381 | Intermediate Similarity | NPC78119 |
0.8378 | Intermediate Similarity | NPC308689 |
0.8378 | Intermediate Similarity | NPC95716 |
0.8364 | Intermediate Similarity | NPC58865 |
0.8362 | Intermediate Similarity | NPC472071 |
0.835 | Intermediate Similarity | NPC27323 |
0.835 | Intermediate Similarity | NPC316301 |
0.835 | Intermediate Similarity | NPC128062 |
0.8349 | Intermediate Similarity | NPC320439 |
0.8349 | Intermediate Similarity | NPC151477 |
0.8348 | Intermediate Similarity | NPC122009 |
0.8347 | Intermediate Similarity | NPC184733 |
0.8347 | Intermediate Similarity | NPC45774 |
0.8347 | Intermediate Similarity | NPC307050 |
0.8347 | Intermediate Similarity | NPC11258 |
0.8347 | Intermediate Similarity | NPC128208 |
0.8347 | Intermediate Similarity | NPC277458 |
0.8347 | Intermediate Similarity | NPC21867 |
0.8347 | Intermediate Similarity | NPC129570 |
0.8347 | Intermediate Similarity | NPC282703 |
0.8333 | Intermediate Similarity | NPC76451 |
0.8319 | Intermediate Similarity | NPC224342 |
0.8319 | Intermediate Similarity | NPC12656 |
0.8318 | Intermediate Similarity | NPC477802 |
0.8318 | Intermediate Similarity | NPC477801 |
0.8317 | Intermediate Similarity | NPC242240 |
0.8317 | Intermediate Similarity | NPC318325 |
0.8317 | Intermediate Similarity | NPC258219 |
0.8317 | Intermediate Similarity | NPC280347 |
0.8317 | Intermediate Similarity | NPC123273 |
0.8317 | Intermediate Similarity | NPC177420 |
0.8305 | Intermediate Similarity | NPC86900 |
0.8305 | Intermediate Similarity | NPC321402 |
0.8305 | Intermediate Similarity | NPC471794 |
0.8305 | Intermediate Similarity | NPC30462 |
0.8304 | Intermediate Similarity | NPC43525 |
0.8304 | Intermediate Similarity | NPC46940 |
0.8302 | Intermediate Similarity | NPC213730 |
0.8302 | Intermediate Similarity | NPC72729 |
0.8291 | Intermediate Similarity | NPC470414 |
0.8288 | Intermediate Similarity | NPC222084 |
0.8288 | Intermediate Similarity | NPC296683 |
0.8288 | Intermediate Similarity | NPC13482 |
0.8286 | Intermediate Similarity | NPC77492 |
0.8286 | Intermediate Similarity | NPC79241 |
0.8286 | Intermediate Similarity | NPC6597 |
0.8279 | Intermediate Similarity | NPC475875 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC254833 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD3022 | Approved |
1.0 | High Similarity | NPD3021 | Approved |
0.9109 | High Similarity | NPD3020 | Approved |
0.8812 | High Similarity | NPD2859 | Approved |
0.8812 | High Similarity | NPD2860 | Approved |
0.8713 | High Similarity | NPD2933 | Approved |
0.8713 | High Similarity | NPD2934 | Approved |
0.8393 | Intermediate Similarity | NPD5283 | Phase 1 |
0.835 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.8214 | Intermediate Similarity | NPD228 | Approved |
0.819 | Intermediate Similarity | NPD288 | Approved |
0.8095 | Intermediate Similarity | NPD844 | Approved |
0.7984 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7982 | Intermediate Similarity | NPD9377 | Approved |
0.7982 | Intermediate Similarity | NPD7635 | Approved |
0.7982 | Intermediate Similarity | NPD9379 | Approved |
0.7963 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7963 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7951 | Intermediate Similarity | NPD3055 | Approved |
0.7951 | Intermediate Similarity | NPD3053 | Approved |
0.7934 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.792 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.7917 | Intermediate Similarity | NPD3092 | Approved |
0.7913 | Intermediate Similarity | NPD2234 | Approved |
0.7913 | Intermediate Similarity | NPD2228 | Approved |
0.7913 | Intermediate Similarity | NPD2229 | Approved |
0.7905 | Intermediate Similarity | NPD845 | Approved |
0.7881 | Intermediate Similarity | NPD3091 | Approved |
0.7876 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7876 | Intermediate Similarity | NPD1792 | Phase 2 |
0.7869 | Intermediate Similarity | NPD5311 | Approved |
0.7869 | Intermediate Similarity | NPD5310 | Approved |
0.7822 | Intermediate Similarity | NPD111 | Approved |
0.7815 | Intermediate Similarity | NPD4093 | Discontinued |
0.7807 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD3094 | Phase 2 |
0.7798 | Intermediate Similarity | NPD3028 | Approved |
0.7787 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7768 | Intermediate Similarity | NPD1444 | Approved |
0.7768 | Intermediate Similarity | NPD1445 | Approved |
0.7757 | Intermediate Similarity | NPD1809 | Phase 2 |
0.775 | Intermediate Similarity | NPD2932 | Approved |
0.775 | Intermediate Similarity | NPD4059 | Approved |
0.775 | Intermediate Similarity | NPD3019 | Approved |
0.7727 | Intermediate Similarity | NPD940 | Approved |
0.7727 | Intermediate Similarity | NPD846 | Approved |
0.7699 | Intermediate Similarity | NPD2342 | Discontinued |
0.7656 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7656 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7619 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7603 | Intermediate Similarity | NPD3095 | Discontinued |
0.7561 | Intermediate Similarity | NPD2337 | Clinical (unspecified phase) |
0.754 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.752 | Intermediate Similarity | NPD4339 | Clinical (unspecified phase) |
0.7519 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7519 | Intermediate Similarity | NPD3062 | Approved |
0.7519 | Intermediate Similarity | NPD3059 | Approved |
0.7519 | Intermediate Similarity | NPD3061 | Approved |
0.746 | Intermediate Similarity | NPD257 | Approved |
0.746 | Intermediate Similarity | NPD258 | Approved |
0.7459 | Intermediate Similarity | NPD9384 | Approved |
0.7459 | Intermediate Similarity | NPD9381 | Approved |
0.7459 | Intermediate Similarity | NPD1751 | Approved |
0.7459 | Intermediate Similarity | NPD2286 | Discontinued |
0.744 | Intermediate Similarity | NPD9634 | Clinical (unspecified phase) |
0.7438 | Intermediate Similarity | NPD5304 | Approved |
0.7438 | Intermediate Similarity | NPD5303 | Approved |
0.7407 | Intermediate Similarity | NPD8166 | Discontinued |
0.7405 | Intermediate Similarity | NPD5314 | Approved |
0.7385 | Intermediate Similarity | NPD943 | Approved |
0.7385 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7385 | Intermediate Similarity | NPD1613 | Approved |
0.7368 | Intermediate Similarity | NPD1632 | Clinical (unspecified phase) |
0.736 | Intermediate Similarity | NPD9622 | Approved |
0.7355 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7339 | Intermediate Similarity | NPD5350 | Clinical (unspecified phase) |
0.7339 | Intermediate Similarity | NPD5351 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD6671 | Approved |
0.7333 | Intermediate Similarity | NPD7157 | Approved |
0.7328 | Intermediate Similarity | NPD2684 | Approved |
0.7317 | Intermediate Similarity | NPD4589 | Approved |
0.7317 | Intermediate Similarity | NPD5238 | Clinical (unspecified phase) |
0.7313 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7313 | Intermediate Similarity | NPD7266 | Discontinued |
0.7288 | Intermediate Similarity | NPD6124 | Clinical (unspecified phase) |
0.7287 | Intermediate Similarity | NPD7095 | Approved |
0.7273 | Intermediate Similarity | NPD7325 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7266 | Intermediate Similarity | NPD5736 | Approved |
0.7258 | Intermediate Similarity | NPD3026 | Approved |
0.7258 | Intermediate Similarity | NPD3023 | Approved |
0.7252 | Intermediate Similarity | NPD826 | Approved |
0.7252 | Intermediate Similarity | NPD825 | Approved |
0.7252 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7236 | Intermediate Similarity | NPD3024 | Approved |
0.7236 | Intermediate Similarity | NPD3025 | Approved |
0.7231 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7231 | Intermediate Similarity | NPD5109 | Approved |
0.7231 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7227 | Intermediate Similarity | NPD7843 | Approved |
0.7209 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7188 | Intermediate Similarity | NPD2194 | Approved |
0.7188 | Intermediate Similarity | NPD9621 | Approved |
0.7188 | Intermediate Similarity | NPD9619 | Approved |
0.7188 | Intermediate Similarity | NPD9620 | Approved |
0.7188 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7188 | Intermediate Similarity | NPD2195 | Approved |
0.7177 | Intermediate Similarity | NPD2667 | Approved |
0.7177 | Intermediate Similarity | NPD2668 | Approved |
0.7176 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7174 | Intermediate Similarity | NPD2422 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD7159 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD4869 | Clinical (unspecified phase) |
0.7154 | Intermediate Similarity | NPD5156 | Approved |
0.7154 | Intermediate Similarity | NPD2226 | Clinical (unspecified phase) |
0.7154 | Intermediate Similarity | NPD5155 | Approved |
0.7143 | Intermediate Similarity | NPD2232 | Approved |
0.7143 | Intermediate Similarity | NPD2230 | Approved |
0.7143 | Intermediate Similarity | NPD2233 | Approved |
0.7132 | Intermediate Similarity | NPD3637 | Approved |
0.7132 | Intermediate Similarity | NPD3636 | Approved |
0.7132 | Intermediate Similarity | NPD3635 | Approved |
0.7132 | Intermediate Similarity | NPD9569 | Approved |
0.713 | Intermediate Similarity | NPD9608 | Approved |
0.713 | Intermediate Similarity | NPD9610 | Approved |
0.7122 | Intermediate Similarity | NPD2421 | Approved |
0.7122 | Intermediate Similarity | NPD2420 | Approved |
0.7119 | Intermediate Similarity | NPD5451 | Approved |
0.7107 | Intermediate Similarity | NPD497 | Approved |
0.7107 | Intermediate Similarity | NPD1791 | Approved |
0.7107 | Intermediate Similarity | NPD475 | Phase 2 |
0.7107 | Intermediate Similarity | NPD1476 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD1793 | Approved |
0.7099 | Intermediate Similarity | NPD598 | Approved |
0.7099 | Intermediate Similarity | NPD601 | Approved |
0.7099 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7099 | Intermediate Similarity | NPD3144 | Approved |
0.7099 | Intermediate Similarity | NPD3145 | Approved |
0.7099 | Intermediate Similarity | NPD597 | Approved |
0.7097 | Intermediate Similarity | NPD1357 | Approved |
0.7087 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7087 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7087 | Intermediate Similarity | NPD4659 | Approved |
0.7083 | Intermediate Similarity | NPD5535 | Approved |
0.7077 | Intermediate Similarity | NPD2605 | Approved |
0.7077 | Intermediate Similarity | NPD2606 | Approved |
0.7071 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7068 | Intermediate Similarity | NPD274 | Approved |
0.7068 | Intermediate Similarity | NPD275 | Approved |
0.7063 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7054 | Intermediate Similarity | NPD4624 | Approved |
0.705 | Intermediate Similarity | NPD3845 | Phase 1 |
0.7045 | Intermediate Similarity | NPD259 | Phase 1 |
0.7045 | Intermediate Similarity | NPD6663 | Approved |
0.7045 | Intermediate Similarity | NPD1136 | Approved |
0.7045 | Intermediate Similarity | NPD1132 | Approved |
0.7045 | Intermediate Similarity | NPD1130 | Approved |
0.7043 | Intermediate Similarity | NPD9500 | Approved |
0.7043 | Intermediate Similarity | NPD5700 | Clinical (unspecified phase) |
0.704 | Intermediate Similarity | NPD4626 | Approved |
0.7031 | Intermediate Similarity | NPD1283 | Approved |
0.7025 | Intermediate Similarity | NPD495 | Approved |
0.7025 | Intermediate Similarity | NPD498 | Approved |
0.7025 | Intermediate Similarity | NPD496 | Approved |
0.7015 | Intermediate Similarity | NPD823 | Approved |
0.7015 | Intermediate Similarity | NPD817 | Approved |
0.7009 | Intermediate Similarity | NPD968 | Approved |
0.7008 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7 | Intermediate Similarity | NPD3018 | Phase 2 |
0.6992 | Remote Similarity | NPD6346 | Approved |
0.6984 | Remote Similarity | NPD3847 | Discontinued |
0.6977 | Remote Similarity | NPD4104 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD4103 | Phase 2 |
0.6963 | Remote Similarity | NPD6896 | Approved |
0.6963 | Remote Similarity | NPD6895 | Approved |
0.696 | Remote Similarity | NPD1651 | Approved |
0.6957 | Remote Similarity | NPD3060 | Approved |
0.6953 | Remote Similarity | NPD6583 | Phase 3 |
0.6953 | Remote Similarity | NPD6582 | Phase 2 |
0.6953 | Remote Similarity | NPD1669 | Approved |
0.6953 | Remote Similarity | NPD4749 | Approved |
0.695 | Remote Similarity | NPD3645 | Discontinued |
0.695 | Remote Similarity | NPD4160 | Clinical (unspecified phase) |
0.6947 | Remote Similarity | NPD3594 | Approved |
0.6947 | Remote Similarity | NPD3595 | Approved |
0.6944 | Remote Similarity | NPD9094 | Approved |
0.694 | Remote Similarity | NPD5735 | Approved |
0.694 | Remote Similarity | NPD6355 | Discontinued |
0.694 | Remote Similarity | NPD555 | Phase 2 |
0.6929 | Remote Similarity | NPD3705 | Approved |
0.6929 | Remote Similarity | NPD1201 | Approved |
0.6923 | Remote Similarity | NPD1969 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD1972 | Approved |
0.6923 | Remote Similarity | NPD1973 | Approved |
0.6911 | Remote Similarity | NPD709 | Approved |
0.6906 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD6331 | Phase 2 |
0.6906 | Remote Similarity | NPD4110 | Phase 3 |
0.6905 | Remote Similarity | NPD6516 | Phase 2 |
0.6905 | Remote Similarity | NPD5846 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.